JT
PRCT icon

Jupiter Topco’s Procept Biorobotics PRCT Stock Holding History

Jupiter Topco’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.9M Buy
+1,103,404
New +$27.6M 0.01% 596

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Jupiter Topco's PRCT Position: Q2 2026 in Review

Jupiter Topco opened a new position in Procept Biorobotics (PRCT) in Q2 2026: 1,103,404 shares worth $24.9M. The stake represents 0.01% of the portfolio and ranks #596 among its holdings.

238 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Jupiter Topco held 1,103,404 shares of Procept Biorobotics worth $24.9M as of Q2 2026.
  • Procept Biorobotics was a new Jupiter Topco position in Q2 2026.
  • Procept Biorobotics made up 0.01% of Jupiter Topco's portfolio in Q2 2026, its #596 holding.
  • 238 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.